Lind Kevin Robert — SEC insider filings

SEC reporting owner CIK 1677036. 14 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2022-02-11 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Longboard Pharmaceuticals, Inc. (LBPH)President and CEO, Director7——17
Apnimed, Inc. (APMD)Chief Executive Officer, Director1——7
Avalo Therapeutics, Inc. (AVTX)Director6——6

Insider filings — Lind Kevin Robert

FiledFormIssuerReported transactionsSource
2026-10-024Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 1,352 (derivative) @ $12.29EDGAR
2026-08-034Apnimed, Inc. (APMD)Disposition to issuer (D): 74,128 (derivative) @ $0 · Grant/award (A): 74,128 (derivative) @ $0 · Disposition to issuer (D): 1,186,278 (derivative) @ $0 · Grant/award (A): 1,186,278 (derivative) @ $0 · Grant/award (A): 108,916 (derivative) @ $0 · Disposition to issuer (D): 108,916 (derivative) @ $0 · +1 moreEDGAR
2026-07-024Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 1,105 (derivative) @ $15.04EDGAR
2026-06-044Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 20,100 (derivative) @ $0EDGAR
2026-04-014Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 1,370 (derivative) @ $12.13EDGAR
2026-01-054Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 848 (derivative) @ $14.74EDGAR
2025-10-024Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 40,200 (derivative) @ $0EDGAR
2024-12-024Longboard Pharmaceuticals, Inc. (LBPH)Code (U): 363,740 @ $60 · Disposition to issuer (D): 255,377 (derivative) · Disposition to issuer (D): 192,783 (derivative) · Disposition to issuer (D): 325,850 (derivative) · Disposition to issuer (D): 332,134 (derivative) · Disposition to issuer (D): 22,000 (derivative)EDGAR
2024-11-134Longboard Pharmaceuticals, Inc. (LBPH)Option exercise (M): 12,808 @ $3.12 · Gift (G): 80,000 @ $0 · Option exercise (M): 12,808 (derivative) @ $0EDGAR
2024-10-294Longboard Pharmaceuticals, Inc. (LBPH)Grant/award (A): 22,000 (derivative) @ $0EDGAR
2024-08-134Longboard Pharmaceuticals, Inc. (LBPH)Option exercise (M): 80,265 @ $3.12 · Option exercise (M): 2,217 @ $4.20 · Option exercise (M): 80,265 (derivative) @ $0 · Option exercise (M): 2,217 (derivative) @ $0EDGAR
2024-02-094Longboard Pharmaceuticals, Inc. (LBPH)Grant/award (A): 332,134 (derivative) @ $0EDGAR
2023-02-104Longboard Pharmaceuticals, Inc. (LBPH)Grant/award (A): 325,850 (derivative) @ $0EDGAR
2022-02-114Longboard Pharmaceuticals, Inc. (LBPH)Grant/award (A): 195,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-02-07 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1677036 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs